BRISTOL INVESTMENT FUND LTD 13D and 13G filings for GT Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-23 8:31 pm Purchase |
2024-05-23 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 190,000 8.800% |
179,162 (+1653.09%) |
Filing |
| 2022-03-02 9:28 pm Sale |
2022-02-28 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 10,838 1.060% |
-28,905 (-72.73%) |
Filing |
| 2021-04-16 07:59 am Purchase |
2021-04-05 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 39,743 4.170% |
26,763 (+206.19%) |
Filing |
| 2021-02-08 3:08 pm Unchanged |
2020-12-31 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 12,980 7.910% |
0 (Unchanged) |
Filing |
| 2020-06-10 08:08 am Purchase |
2020-06-08 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 12,980 9.360% |
5,933 (+84.18%) |
Filing |
| 2020-05-18 4:06 pm Purchase |
2020-05-15 | 13G | GT Biopharma, Inc. GTBP |
BRISTOL INVESTMENT FUND LTD | 7,047 5.080% |
1,132 (+19.14%) |
Filing |